• U.K.
    • USA
    • GER
    • CHI
    • FRA
    • PT(BR)

Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare

  • U.K.
    • USA
    • GER
    • CHI
    • FRA
    • PT(BR)
  • Resources
    • FAQs
    • Quality Certificates
    • Studies & Publications
    • Bioquell QuAD Data Portal
    • Safety Data Sheets
  • News & Events
  • About
    • Company
    • Company Locations
    • Distributors
    • Careers
    • Ecolab Life Sciences
  • Pharmaceuticals & Life Sciences
    • Bioquell and COVID-19
    • Our Technology for Life Sciences
    • Why Bioquell Technology?
    • Systems for Life Sciences
    • Rapid Bio Decontamination Service
    • Validation
    • Consumables and Related Accessories
    • Ecolab Life Sciences
  • Healthcare & EMS
    • Bioquell and COVID-19
    • Why Bioquell Technology?
    • Our Technology for Healthcare
    • Bioquell Compared to UV
    • Aerosolised Versus Bioquell’s Hydrogen Peroxide Vapour
    • Systems for Healthcare
    • Services for Healthcare
    • Emergency Medical Services
    • Consumables and Related Accessories
  • Rapid Bio Decontamination Service
    • Bioquell and COVID-19
    • For Life Sciences
    • For Healthcare
    • Business Continuity
    • RBDS Applications
      • Remediation Needs
      • Emergency Response
      • Disaster Recovery Plan
      • Commissioning
      • End of Campaign and Facility Restart
      • Lab and Research Spaces
      • Hospital Related Contamination Events
  • Qube Isolator
  • Contact
notification

Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.

Click here for more information

x
    • Pharmaceuticals & Life Sciences
      • Bioquell and COVID-19
      • Our Technology for Life Sciences
      • Why Bioquell Technology?
      • Systems for Life Sciences
      • Rapid Bio Decontamination Service
      • Validation
      • Consumables and Related Accessories
      • Ecolab Life Sciences
    • Healthcare & EMS
      • Bioquell and COVID-19
      • Why Bioquell Technology?
      • Our Technology for Healthcare
      • Bioquell Compared to UV
      • Aerosolised Versus Bioquell’s Hydrogen Peroxide Vapour
      • Systems for Healthcare
      • Services for Healthcare
      • Emergency Medical Services
      • Consumables and Related Accessories
    • Rapid Bio Decontamination Service
      • Bioquell and COVID-19
      • For Life Sciences
      • For Healthcare
      • Business Continuity
      • RBDS Applications
        • Remediation Needs
        • Emergency Response
        • Disaster Recovery Plan
        • Commissioning
        • End of Campaign and Facility Restart
        • Lab and Research Spaces
        • Hospital Related Contamination Events
    • Qube Isolator
    • Contact

News

Preparing for lasting challenges of COVID-19

April 2021

Click here to download the PDF version of this story from the Clinical Services Journal. Due to pressures from highly contagious pathogens, healthcare facilities are seeking all-inclusive offerings to handle decontamination responsibilities and discovering unique solutions for creating private patient areas. Measures to help slow the spread of healthcare-associated infections (HCAIs), including COVID-19, require a […]

Read More

Higher Hygiene Standards for Infection Control

January 2021

In this Clinical Services Journal article, the topic of innovative decontamination efforts and hand hygiene tools are reviewed to show how they have helped hospitals raise infection control standards during the pandemic. Hospitals across the world saw cases rise while also dealing with unique challenges, whether PPE shortages, supply and staff issues, or finding effective […]

Read More

Bioquell Helping Pharmaceutical Companies Resume Operations Post COVID-19

June 2020

Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity As the world prepares to enter the next phase of the COVID-19 pandemic with the potential relaxation of lockdown restrictions, Bioquell, an Ecolab solution and leading manufacturer of high performance bio-decontamination technology, is utilizing its well-proven […]

Read More

Bioquell Rapid Bio-decontamination Service Helps Eliminate Spores in a Major Pharmaceutical Manufacturing Facility in Wuhan, China

June 2020

Following the COVID-19 lockdown, environmental monitoring at a major international provider of Biologics Contract Development and Manufacturing Organisations (CDMO) services in Wuhan, China indicated spore contamination in a production room. Despite exhausting all disinfection methods in its records, including the manual application of a sporicide, there was a repeated failure of the EM test standards. […]

Read More

Bioquell Rapid Bio-decontamination Service Returns Converted COVID-19 Hospital Wards Back to Normal Use

June 2020

During the COVID-19 pandemic, many hospital wards were temporarily converted to solely treat COVID-19 patients. As these begin to revert back to ‘regular’ non COVID-19 wards, a solution is required to manage the increased potential contamination risk facing the patients admitted to these wards. Our latest case study highlights how Bioquell’s RBDS recently returned an […]

Read More

One Large New Zealand Hospital Has Chosen Bioquell to Combat COVID-19

April 2020

One of New Zealand’s largest hospitals has chosen to purchase their first Bioquell BQ-50 suite to help them combat COVID-19. The hospital is well versed in performing airborne disinfection with alternative technologies but has selected Bioquell to improve their decontamination capabilities.  The Bioquell BQ-50 has been chosen due to its emphasis on operator and patient […]

Read More

UK Hospital Acquires Bioquell PODs to Help Control Infection Outbreaks

April 2020

A hospital in Kent has recently purchased 3 Bioquell PODs after identifying that their current set-up was not adequate for viral or bacterial infection outbreaks. The plan is to transform part of their High Dependency Unit into segregated areas using the Bioquell PODs. The Bioquell POD is an ideal solution for converting open wards to […]

Read More

Bioquell Involvement in the Latest Study from Duke

March 2020

Bioquell hydrogen peroxide vapor technology has been used in Duke’s latest study. See a link to the study and other news here: https://www.dukechronicle.com/article/2020/03/duke-health-researchers-decontaminate-n95-face-masks-reuse

Read More

FDA grants an Emergency Use Authorization for Battelle

March 2020

Bioquell, an Ecolab Solution, is in the news as the FDA grants an Emergency Use Authorization (EUA) for Battelle and its CCDS Critical Care Decontamination System. See the full story here about the efforts taking place with this a Columbus-based non-profit. Read more on USA Today.

Read More

State–of-the-art decontamination machines help to keep Lincoln hospitals bug-free

March 2020

An article recently featured in Building Better Healthcare discusses how one hospital is using Bioquell BQ-50 systems to help to stop the spread of norovirus, MRSA, and other drug-resistant micro-organisms. It reviews Bioquell’s technology and how it is ideal for hospital settings. Importantly, the article states that Bioquell technology “can get into all of the […]

Read More
Tags
All
1 2 3 4 >>

Sales and Technical Support & General Enquiries: +44 (0)1264 835 835

52 Royce Cl, Andover SP10 3TS, UK

[email protected]

  • © Bioquell, An Ecolab Solution 2025 All Rights Reserved
  • Privacy Policy
  • Terms of Use
Download PDF